| Market Cap | 195.18M | P/E | - | EPS this Y | 51.40% | Ern Qtrly Grth | - |
| Income | -30.32M | Forward P/E | -9.18 | EPS next Y | 55.60% | 50D Avg Chg | 1.00% |
| Sales | 278.98M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -34.00% |
| Dividend | N/A | Price/Book | 0.39 | EPS next 5Y | - | 52W High Chg | -72.00% |
| Recommedations | 2.70 | Quick Ratio | 1.25 | Shares Outstanding | 54.66M | 52W Low Chg | 14.00% |
| Insider Own | - | ROA | -1.87% | Shares Float | 54.42M | Beta | 2.72 |
| Inst Own | 13.34% | ROE | -6.13% | Shares Shorted/Prior | 2.73M/2.32M | Price | 0.55 |
| Gross Margin | 53.76% | Profit Margin | -11.53% | Avg. Volume | 4,109,314 | Target Price | 31.90 |
| Oper. Margin | 2.25% | Earnings Date | Nov 7 | Volume | 5,222,745 | Change | -4.59% |
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.